Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3

The role of phosphodiesterase 3 (PDE3), a cyclic AMP (cAMP)-degrading enzyme, in modulating gluconeogenesis remains unknown. Here, linderane, a natural compound, was found to inhibit gluconeogenesis by activating hepatic PDE3 in rat primary hepatocytes. The underlying molecular mechanism and its eff...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Wei Xie, Yangliang Ye, Ying Feng, Tifei Xu, Suling Huang, Jianhua Shen, Ying Leng
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2018-05-01
Schriftenreihe:	Frontiers in Pharmacology
Schlagworte:	cAMP gluconeogenesis linderane phosphodiesterase type 2 diabetes
Online-Zugang:	http://journal.frontiersin.org/article/10.3389/fphar.2018.00476/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!